Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Primate cell – per se
Reexamination Certificate
2007-05-15
2007-05-15
Qian, Celine (Department: 1636)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Primate cell, per se
C435S366000, C435S325000, C435S455000
Reexamination Certificate
active
10805536
ABSTRACT:
The present invention provides novel cell lines that may have improved adhesive qualities, transgene expression level, growth rate, and/or growth rate in serum free medium or even chemically defined compared to cells of the prior art.
REFERENCES:
patent: 5547932 (1996-08-01), Curiel et al.
patent: 5683903 (1997-11-01), Lysko et al.
patent: 5863798 (1999-01-01), Lysko et al.
patent: 5919636 (1999-07-01), Lysko et al.
patent: 2003/0096414 (2003-05-01), Ciccarone et al.
patent: WO 02/090533 (2002-11-01), None
Yao et al. Laminins promote the locomotion of skeletal myoblasts via the alpha 7 integrin receptor. J Cell Sci. vol. 109, Pt 13, pp. 3139-3150, Dec. 1996.
Robbins et al. Macrophage scavenger receptor confers an adherent phenotype to cells in culture. Biotechniques. vol. 25, No. 2, pp. 240-244, Aug. 1998.
Roy et al. “High Transfection Efficiency of Cloned Cell Lines,” Focus, vol. 21, pp. 62-63, Life Technologies, 1999.
Cassoni et al. “GeneSwitch™ -It Stays Off Until You Turn it On,” Expressions, vol. 6, pp. 1-15, Invitrogen Corporation, 1999.
2000 Invitrogen Catalog, Invitrogen Corporation, 2000, pp. 111-113.
Pear et al. Production of high-titer helper-free retroviruses by transient transfection. PNAS, USA, vol. 90, pp. 8392-8396, Sep. 1993.
Harms et al. Interfreron-gamma inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter. Human Gene Therapy, vol. 6, No. 10, pp. 1291-1297, 1995.
Cote et al. Seum-free production of recombinant proteins and adenoviral vectors by 293SF-3F6 cells. Biotechnology and Bioengineering, vol. 56, No. 5, Sep. 1998, 567-575.
Elbashir, S.M., et al., “Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells,”Nature 411:494-498, Macmillan Magazines Ltd. (2001).
Finn, B., et al., “Hit the ground running: Ultimate Human ORF Clones--Sequence-verified and ready to use,”Expressions10:16, Invitrogen Corporation (Feb. 2003).
Aiyar, N., et al., “Human AT1receptor is a single copy gene: characterization in a stable cell line,”Mol. Cell. Biochem. 131:75-86, Kluwer Academic Publishers (1994).
Ashkenas, J., et al., “Structures and high and low affinity ligand binding properties of murine type I and type II macrophage scavenger receptors,”J. Lipid Res. 34:983-1000, Federation of American Societies for Experimental Biology (1993).
Baek, S., et al., “Sustainable Systemic Delivery via a Single Injection of Lentivirus into Human Skin Tissue,”Hum. Gene Ther. 12:1551-1558, M.A. Liebert (2001).
Bickel, P.E., and Freeman, M.W., “Rabbit Aortic Smooth Muscle Cells Express Inducible Macrophage Scavenger Receptor Messenger RNA That Is Absent from Endothelial Cells,”J. Clin. Invest. 90:1450-1457, The American Society for Clinical Investigation (1992).
Buchschacher, G.L., and Wong-Staal, F., “Developmentof lentiviral vectors for gene therapy for human diseases,”Blood 95:2499-2504, The American Society of Hematology (2000).
Dull, T., et al., “A Third-Generation Lentivirus Vector with a Conditional Packaging System,”J. Virol. 72:8463-8471, American Society for Microbiology (1998).
Freeman, M., et al., “An ancient, highly conserved family of cysteine-rich protein domains revealed by cloning type I and type II murine macrophage scavenger receptors,”Proc. Natl. Acad. Sci. USA 87:8810-8814, National Academy of Sciences (1990).
Gronostajski, R.M., and Sadowski, P.D., “Determination of DNA Sequences Essential for FLP-mediated Recombination by a Novel Method,”J. Biol. Chem. 260:12320-12327, The American Society of Biological Chemists, Inc. (1985).
Invitrogen™ , “Growth and Maintenance of the 293FT Cell Line,” Invitrogen™ Catalog No. R700-07, Version C, Invitrogen Corporation, pp. 1-10 (Mar. 2003).
Invitrogen™ , “Growth and Maintenance of Flp-In Cell Lines,” Invitrogen™ Catalog, Catalog Nos. R750-07, R752-07, R758-07, R760-07, R761-07, R762-07, Version E , Invitrogen Corporation, pp. 1-16 (Feb. 2003).
Invitrogen™ , “Growth and Maintenance of the Freestyle™ 293-F Cell Line,” Invitrogen™ Catalog, Catalog No. R790-07, Version B , Invitrogen Corporation, pp. 1-11 (Aug. 2002).
Invitrogen™ , “Growth and Maintenance of the Grip Tite™ 293 MSR Cell Line,” Invitrogen™ Instruction Manual, Catalog No. R795-07, Version A , Invitrogen Corporation, pp. 1-20(Mar. 2003).
Kodama, T., et al., “Purification and characterization of a bovine acetyl low density lipoprotein receptor,”Proc. Natl. Acad. Sci. USA 85:9238-9242, National Academy of Sciences (1988).
Kodama, T., et al., “Type I macrophage scavenger receptor contains a-helical and collagen-like coiled coils,”Nature 343:531-535, Nature Publishing Group (1990).
Landy, A., “Mechanistic and structural complexity in the site-specific recombination pathways of Int and FLP,”Curr. Opin. Genet. Dev. 3:699-707, Current Biology Ltd (1993).
Lewis, P.F., and Emerman, M., “Passage through Mitosis Is Required for Oncoretroviruses but Not for the Human Immunodeficiency Virus,”J. Virol. 68:510-516, American Society for Microbiology (1994).
Matsumoto, A., et al., “Human macrophage scavenger receptors: Primary structure, expression and localization In atherosclerotic lesions,”Proc. Natl. Acad. Sci. USA 87:9133-9137, National Academy of Sciences (1990).
Miller, D.G., et al., “Gene Transfer by Retrovirus Vectors Occurs Only in Cells That Are Actively Replicating at the Time of Infection,”Mol. Cell. Biol. 10:4239-4242, American Society for Microbiology (1990).
Miller, A.D., and Rosman, G.J., “Improved Retroviral Vectors for Gene Transfer and Expressions,”Bio Techniques 7:980-990, Eaton Publishing Co. (1989).
Mochizuki, H., et al., “High-Titer Human Immunodeficiency Virus Type 1-Based Vector Systems for Gene Delivery into Nondlviding Cells,”J. Virol. 72:8873-8883, American Society of Microbiology (1998).
Naldini, L., and Verma, I.M., “Lentiviral Vectors,” inThe Development of Human Gene Therapy, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 47-60 (1999).
Naldini, L., et al., “Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector,”Proc. Natl. Acad. Sci. USA 93:11382-11388, National Academy of Sciences (1996).
Ohara, O., and Temple, G., “Directional cDNA library construction assisted by thein vitrorecombination reaction,”Nucleic Acids Res. 29:E22, Oxford University Press (2001).
Park, F., and Kay, M.A., “Modified HIV-1 Based Lentiviral Vectors Have an Effect on Viral Transduction Efficiency and Gene Expressionin Vitroandin Vivo” Mol. Ther. 4:164-173, The American Society of Gene Therapy (2001).
Pearson, A.M., et al., “Polynucleotide Binding to Machrophage Scavenger Receptors Depends on the Formation of Base-quartet-stablized Four-stranded Helices,”J. Biol. Chem. 268:3546-3554, The American Society for Biochemistry and Molecular Biology, Inc. (1993).
Peng, K.W., et al., “Organ distribution of gene expression after intravenous infusion of targeted and untargeted lentiviral vectors,”Gene Ther, 8:1456-1463, Nature Publishing Group (2001).
Sambrook, J., et al., “Assay for β-Galactosidase in Extracts of Mammalian Cells,” inMolecular Cloning: A Laboratory Manual, Cold Spring Harbor Press, Cold Spring Harbor, NY, pp. 16.66-16.67 (1989).
Sauer, B., “Site-specific recombination: developments and applications,”Curr. Opin. Biotechnol. 5:521-527, Current Biology (1994).
Seki, S., et al., “Differential Effects of Aphidicollin on Replicative DNA Synthesis and Unscheduled DNA Synthesis In Permeable Mouse Sacroma Cells,”Biochem. Biophys. Acta. 610:413-420, Elsevie
Cates Sharon
Ciccarone Valentina C.
Gruber Dale F.
Hawley-Nelson Pamela
Dunston Jennifer
Golightly Douglas A.
Invitrogen Corporation
LandOfFree
Attached cell lines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Attached cell lines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Attached cell lines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3821842